Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07221409 · ClinicalTrials.gov registry record · NA

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

A NA study of Depression and Cancer, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT07221409: Recruiting NA study of Depression and Cancer, sponsored by Mayo Clinic.

NCT07221409 is a NA study of Depression and Cancer that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07221409, a NA study of Depression and Cancer, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This clinical trial tests the safety, tolerability, and effectiveness of a virtual reality intervention to improve psychological symptom burden for cancer patients undergoing treatment. Virtual reality (VR) is a technology that allows users to experience and interact with three-dimensional, computer-generated environments that simulate the real world or imagined settings. The VR intervention consists of a preloaded with immersive environments designed to engage the senses through simulated sights and sounds. This may include a walk through of a serene forest, exploring vibrant coral reefs, swimming with dolphins, or standing at the base of a majestic waterfall. These environments are created to provide a relaxing and engaging experience. Completing the VR intervention may be a safe and effective way to improve quality of life, reduce anxiety, enhance focus, and promote healthy living for cancer patients undergoing treatment.

Primary Outcome

Feasibility of VR will be assessed by the proportion of participants who successfully complete the intervention.

Conditions Studied

Depression Cancer Malignant Solid Neoplasm Hematopoietic and Lymphoid System Neoplasm Anxiety Disorder Adjustment Disorder

Interventions

  • OTHER Questionnaire Administration
  • OTHER Virtual Reality (VR) Intervention

Study Locations (1)

Florida

  • Mayo Clinic in Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-10-08
Est. Completion 2027-10-08
Phase NA
Mayo Clinic

2,844 total trials

What NCT07221409 shows while recruiting

NCT07221409 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower).

The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT07221409 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07221409 about?

NCT07221409 is a clinical study titled "Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment". This clinical trial tests the safety, tolerability, and effectiveness of a virtual reality intervention to improve psychological symptom burden for cancer patients undergoing treatment. Virtual reality (VR) is a technology that allows users to experience and interact with three-dimensional, computer...

What is the current status of trial NCT07221409?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-10-08. Estimated completion is 2027-10-08.

What conditions does trial NCT07221409 study?

This clinical trial studies the following conditions: Depression, Cancer, Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm, Anxiety Disorder.

What interventions are being tested in trial NCT07221409?

The interventions under investigation include: Questionnaire Administration (OTHER), Virtual Reality (VR) Intervention (OTHER).

Who is sponsoring clinical trial NCT07221409?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07221409 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07221409's enrollment target sits among peer trials

24 594th of 679 higher than 79 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

More recruiting context for NCT07221409

Source: ClinicalTrials.gov NCT07221409, the US trial registry maintained by the National Library of Medicine. NCT07221409 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.